Sarepta Therapeutics
SRPT
SRPT
462 hedge funds and large institutions have $10.7B invested in Sarepta Therapeutics in 2024 Q4 according to their latest regulatory filings, with 77 funds opening new positions, 157 increasing their positions, 158 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.96% more ownership
Funds ownership: 91.12% → 92.07% (+0.96%)
1% less repeat investments, than reductions
Existing positions increased: 157 | Existing positions reduced: 158
1% less capital invested
Capital invested by funds: $10.8B → $10.7B (-$152M)
Holders
462
Holding in Top 10
11
Calls
$211M
Puts
$184M
Top Buyers
| 1 | +$299M | |
| 2 | +$137M | |
| 3 | +$94.4M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$52.5M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$34.9M |
Top Sellers
| 1 | -$94.1M | |
| 2 | -$80.6M | |
| 3 | -$66.5M | |
| 4 |
Man Group
London,
United Kingdom
|
-$38.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$37.8M |